Product/Composition:- | Prolonged-release Potassium Chloride Generics |
---|---|
Strength:- | 8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg) |
Form:- | Tablet |
Reference Brands:- | Klor-Con®, K-Dur®, K-Tab®, Micro-K® (US), KCl Retard®, Kaleorid®, Kalium-Retard®, Slow-K® (EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Prolonged-release Potassium Chloride is an oral electrolyte supplement used to treat and prevent hypokalemia, especially in CKD and patients on diuretics, offering controlled potassium release for stable serum levels.
Prolonged-release Potassium Chloride is a vital electrolyte supplement used to treat and prevent hypokalemia in patients with chronic kidney disease (CKD), heart conditions, or those on diuretic therapy. Designed for steady potassium release, it helps maintain optimal serum potassium levels, reducing the risk of cardiac arrhythmias and muscle dysfunction. Widely prescribed in both the US and EU, it plays a crucial role in nephrology and cardiology. Ideal for B2B pharmaceutical supply, it is available in various strengths to meet diverse patient needs. Prolonged-release Potassium Chloride supports safe, effective potassium repletion in renal and electrolyte management protocols.